Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

BioCryst Pharmaceuticals Inc Share Price

BCRX

NSQ

$7.26

+$0.31

(4.46%)

Industry: Biotechnology Sector: Health Care

BioCryst Pharmaceuticals Inc Analyst Forecast

Overview Returns Financials Ratios News FAQs

BioCryst Pharmaceuticals Inc Share Price Chart

BioCryst Pharmaceuticals Inc Key Stock Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$1.72B

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

4.68M

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

0.79

52-week Range info-icon

This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$6 L

$11.31 H

$7.26

About BioCryst Pharmaceuticals Inc, Common Stock

BioCryst Pharmaceuticals, Inc., a biotechnology company, develops oral small-molecule and injectable protein therapeutics to treat rare diseases. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX17725, a protein therapeutic for netherton syndrome which is in phase 1; Avoralstat, an ocular plasma kallikrein inhibitor for diabetic macular edema that is in preclinical phase; and BCX10013, an oral Factor D inhibitor for complement-mediated diseases, as well as developing Oral C5 Inhibitor and Oral C2 Inhibitor. It also engages in the discovery, development, and commercialization of therapeutics for allergic and immunological diseases. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Shionogi & Co., Ltd., Green Cross Corporation; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina. more

Industry: BiotechnologySector: Health Care

BioCryst Pharmaceuticals Inc Stock Returns

Time Frame	BCRX	Sector	S&P500
1-Week Return	1.61%	0.72%	-1.31%
1-Month Return	4.2%	1.27%	0.78%
3-Month Return	-0.71%	3.13%	3.46%
6-Month Return	-17.06%	15.81%	6.19%
1-Year Return	-25.75%	8.89%	11.68%
3-Year Return	-19.56%	20.79%	71.21%
5-Year Return	-35.65%	35.89%	74.81%
10-Year Return	240.69%	138.44%	256.59%

Time Frame	BCRX	Sector	S&P500
1-Week Return	129.98%	45.37%	-49.72%
1-Month Return	64.96%	16.60%	9.91%
3-Month Return	-2.85%	13.31%	14.79%
6-Month Return	-31.57%	34.67%	12.95%
1-Year Return	-25.75%	8.89%	11.68%
3-Year Return	-7.00%	6.50%	19.63%
5-Year Return	-8.44%	6.33%	11.82%
10-Year Return	13.04%	9.08%	13.56%

BioCryst Pharmaceuticals Inc Financials

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Revenue	17.81M	157.17M	270.83M	331.41M	450.71M	[{"date":"2020-12-31","value":3.95,"profit":true},{"date":"2021-12-31","value":34.87,"profit":true},{"date":"2022-12-31","value":60.09,"profit":true},{"date":"2023-12-31","value":73.53,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue	1.68M	7.26M	6.59M	4.66M	12.48M	[{"date":"2020-12-31","value":13.42,"profit":true},{"date":"2021-12-31","value":58.18,"profit":true},{"date":"2022-12-31","value":52.82,"profit":true},{"date":"2023-12-31","value":37.33,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit	16.14M	149.91M	264.23M	326.75M	438.23M	[{"date":"2020-12-31","value":3.68,"profit":true},{"date":"2021-12-31","value":34.21,"profit":true},{"date":"2022-12-31","value":60.3,"profit":true},{"date":"2023-12-31","value":74.56,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin	90.59%	95.38%	97.57%	98.59%	97.23%	[{"date":"2020-12-31","value":91.88,"profit":true},{"date":"2021-12-31","value":96.74,"profit":true},{"date":"2022-12-31","value":98.96,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":98.62,"profit":true}]

Operating Expenses	190.89M	327.63M	412.67M	430.46M	440.77M	[{"date":"2020-12-31","value":43.31,"profit":true},{"date":"2021-12-31","value":74.33,"profit":true},{"date":"2022-12-31","value":93.62,"profit":true},{"date":"2023-12-31","value":97.66,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income	(174.76M)	(177.72M)	(148.44M)	(103.71M)	(2.54M)	[{"date":"2020-12-31","value":-17475700000,"profit":false},{"date":"2021-12-31","value":-17772000000,"profit":false},{"date":"2022-12-31","value":-14843500000,"profit":false},{"date":"2023-12-31","value":-10370900000,"profit":false},{"date":"2024-12-31","value":-254300000,"profit":false}]
Total Non-Operating Income/Expense	(13.14M)	(63.32M)	(189.91M)	(218.62M)	(168.18M)	[{"date":"2020-12-31","value":-1313800000,"profit":false},{"date":"2021-12-31","value":-6332100000,"profit":false},{"date":"2022-12-31","value":-18991300000,"profit":false},{"date":"2023-12-31","value":-21861800000,"profit":false},{"date":"2024-12-31","value":-16818100000,"profit":false}]
Pre-Tax Income	(182.81M)	(181.81M)	(244.38M)	(226.23M)	(86.95M)	[{"date":"2020-12-31","value":-18281400000,"profit":false},{"date":"2021-12-31","value":-18180900000,"profit":false},{"date":"2022-12-31","value":-24438300000,"profit":false},{"date":"2023-12-31","value":-22622900000,"profit":false},{"date":"2024-12-31","value":-8695400000,"profit":false}]
Income Taxes	13.75M	2.25M	2.73M	310.00K	1.93M	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":16.38,"profit":true},{"date":"2022-12-31","value":19.87,"profit":true},{"date":"2023-12-31","value":2.25,"profit":true},{"date":"2024-12-31","value":14.01,"profit":true}]
Income After Taxes	(196.57M)	(184.06M)	(247.12M)	(226.54M)	(88.88M)	[{"date":"2020-12-31","value":-19656700000,"profit":false},{"date":"2021-12-31","value":-18406200000,"profit":false},{"date":"2022-12-31","value":-24711600000,"profit":false},{"date":"2023-12-31","value":-22653900000,"profit":false},{"date":"2024-12-31","value":-8888100000,"profit":false}]

Income From Continuous Operations	(192.23M)	(184.06M)	(247.12M)	(236.35M)	(88.88M)	[{"date":"2020-12-31","value":-19223400000,"profit":false},{"date":"2021-12-31","value":-18406200000,"profit":false},{"date":"2022-12-31","value":-24711700000,"profit":false},{"date":"2023-12-31","value":-23634900000,"profit":false},{"date":"2024-12-31","value":-8888100000,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	(182.81M)	(184.06M)	(247.12M)	(226.54M)	(88.88M)	[{"date":"2020-12-31","value":-18281400000,"profit":false},{"date":"2021-12-31","value":-18406200000,"profit":false},{"date":"2022-12-31","value":-24711600000,"profit":false},{"date":"2023-12-31","value":-22653900000,"profit":false},{"date":"2024-12-31","value":-8888100000,"profit":false}]

EPS (Diluted)	(1.08)	(1.03)	(1.33)	(0.99)	(0.43)	[{"date":"2020-12-31","value":-108,"profit":false},{"date":"2021-12-31","value":-103,"profit":false},{"date":"2022-12-31","value":-133,"profit":false},{"date":"2023-12-31","value":-99,"profit":false},{"date":"2024-12-31","value":-43,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Revenue	-	782.38%	72.31%	22.37%	36.00%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":9.24,"profit":true},{"date":"2023-12-31","value":2.86,"profit":true},{"date":"2024-12-31","value":4.6,"profit":true}]
Cost of Revenue	-	333.41%	(9.22%)	(29.31%)	167.86%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-2.77,"profit":false},{"date":"2023-12-31","value":-8.79,"profit":false},{"date":"2024-12-31","value":50.35,"profit":true}]
Gross Profit	-	829.02%	76.27%	23.66%	34.12%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":9.2,"profit":true},{"date":"2023-12-31","value":2.85,"profit":true},{"date":"2024-12-31","value":4.12,"profit":true}]
Gross Margin	-	5.28%	2.29%	1.05%	(1.38%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":43.39,"profit":true},{"date":"2023-12-31","value":19.94,"profit":true},{"date":"2024-12-31","value":-26.17,"profit":false}]

Operating Expenses	-	71.63%	25.96%	4.31%	2.40%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":36.24,"profit":true},{"date":"2023-12-31","value":6.02,"profit":true},{"date":"2024-12-31","value":3.34,"profit":true}]
Operating Income	-	1.70%	(16.48%)	(30.13%)	(97.55%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-971.88,"profit":false},{"date":"2023-12-31","value":-1777.16,"profit":false},{"date":"2024-12-31","value":-5753.35,"profit":false}]
Total Non-Operating Income/Expense	-	381.97%	199.92%	15.11%	(23.07%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":52.34,"profit":true},{"date":"2023-12-31","value":3.96,"profit":true},{"date":"2024-12-31","value":-6.04,"profit":false}]
Pre-Tax Income	-	(0.55%)	34.42%	(7.43%)	(61.56%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-1.6,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-21.58,"profit":false},{"date":"2024-12-31","value":-178.87,"profit":false}]
Income Taxes	-	(83.62%)	21.30%	(88.66%)	521.61%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-16.03,"profit":false},{"date":"2022-12-31","value":4.08,"profit":true},{"date":"2023-12-31","value":-17,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income After Taxes	-	(6.36%)	34.26%	(8.33%)	(60.77%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-18.57,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-24.31,"profit":false},{"date":"2024-12-31","value":-177.38,"profit":false}]

Income From Continuous Operations	-	(4.25%)	34.26%	(4.36%)	(62.39%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-12.41,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-12.72,"profit":false},{"date":"2024-12-31","value":-182.13,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income	-	0.68%	34.26%	(8.33%)	(60.77%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":1.99,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-24.31,"profit":false},{"date":"2024-12-31","value":-177.38,"profit":false}]

EPS (Diluted)	-	(4.63%)	29.13%	(25.56%)	(56.57%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-15.9,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-87.77,"profit":false},{"date":"2024-12-31","value":-194.21,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	117.08M	131.53M	145.53M	163.35M	159.40M	[{"date":"2024-09-30","value":71.68,"profit":true},{"date":"2024-12-31","value":80.52,"profit":true},{"date":"2025-03-31","value":89.09,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":97.58,"profit":true}]
Cost of Revenue	3.23M	6.13M	4.57M	2.80M	2.52M	[{"date":"2024-09-30","value":52.65,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":74.51,"profit":true},{"date":"2025-06-30","value":45.64,"profit":true},{"date":"2025-09-30","value":41.14,"profit":true}]
Gross Profit	113.86M	125.40M	140.97M	160.56M	156.87M	[{"date":"2024-09-30","value":70.91,"profit":true},{"date":"2024-12-31","value":78.11,"profit":true},{"date":"2025-03-31","value":87.8,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":97.71,"profit":true}]
Gross Margin	97.24%	95.34%	96.86%	98.29%	98.42%	[{"date":"2024-09-30","value":98.81,"profit":true},{"date":"2024-12-31","value":96.87,"profit":true},{"date":"2025-03-31","value":98.42,"profit":true},{"date":"2025-06-30","value":99.87,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Operating Expenses	106.17M	129.91M	119.74M	130.77M	127.28M	[{"date":"2024-09-30","value":81.19,"profit":true},{"date":"2024-12-31","value":99.34,"profit":true},{"date":"2025-03-31","value":91.57,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":97.33,"profit":true}]
Operating Income	7.69M	(4.51M)	21.23M	29.79M	29.59M	[{"date":"2024-09-30","value":25.82,"profit":true},{"date":"2024-12-31","value":-15.13,"profit":false},{"date":"2025-03-31","value":71.27,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":99.35,"profit":true}]
Total Non-Operating Income/Expense	(42.38M)	(42.36M)	(40.94M)	(42.37M)	(34.88M)	[{"date":"2024-09-30","value":-4237600000,"profit":false},{"date":"2024-12-31","value":-4236200000,"profit":false},{"date":"2025-03-31","value":-4093900000,"profit":false},{"date":"2025-06-30","value":-4236600000,"profit":false},{"date":"2025-09-30","value":-3488400000,"profit":false}]
Pre-Tax Income	(13.45M)	(25.99M)	758.00K	6.49M	12.13M	[{"date":"2024-09-30","value":-110.86,"profit":false},{"date":"2024-12-31","value":-214.27,"profit":false},{"date":"2025-03-31","value":6.25,"profit":true},{"date":"2025-06-30","value":53.47,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Income Taxes	586.00K	804.00K	726.00K	1.40M	(769.00K)	[{"date":"2024-09-30","value":41.83,"profit":true},{"date":"2024-12-31","value":57.39,"profit":true},{"date":"2025-03-31","value":51.82,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-54.89,"profit":false}]
Income After Taxes	(14.03M)	(26.80M)	32.00K	5.08M	12.90M	[{"date":"2024-09-30","value":-108.79,"profit":false},{"date":"2024-12-31","value":-207.73,"profit":false},{"date":"2025-03-31","value":0.25,"profit":true},{"date":"2025-06-30","value":39.42,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Income From Continuous Operations	(14.03M)	(26.80M)	32.00K	5.08M	12.90M	[{"date":"2024-09-30","value":-108.79,"profit":false},{"date":"2024-12-31","value":-207.73,"profit":false},{"date":"2025-03-31","value":0.25,"profit":true},{"date":"2025-06-30","value":39.42,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	(14.03M)	(26.80M)	32.00K	5.08M	12.90M	[{"date":"2024-09-30","value":-108.79,"profit":false},{"date":"2024-12-31","value":-207.73,"profit":false},{"date":"2025-03-31","value":0.25,"profit":true},{"date":"2025-06-30","value":39.42,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

EPS (Diluted)	(0.07)	(0.13)	0.00	0.02	0.16	[{"date":"2024-09-30","value":-43.75,"profit":false},{"date":"2024-12-31","value":-81.25,"profit":false},{"date":"2025-03-31","value":0.06,"profit":true},{"date":"2025-06-30","value":12.5,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	-	12.34%	10.64%	12.24%	(2.42%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":86.25,"profit":true},{"date":"2025-06-30","value":99.22,"profit":true},{"date":"2025-09-30","value":-19.63,"profit":false}]
Cost of Revenue	-	89.93%	(25.49%)	(38.75%)	(9.86%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-28.35,"profit":false},{"date":"2025-06-30","value":-43.09,"profit":false},{"date":"2025-09-30","value":-10.97,"profit":false}]
Gross Profit	-	10.14%	12.41%	13.90%	(2.29%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":72.97,"profit":true},{"date":"2025-03-31","value":89.31,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-16.5,"profit":false}]
Gross Margin	-	(1.96%)	1.60%	1.47%	0.13%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-122.63,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":92.19,"profit":true},{"date":"2025-09-30","value":8.32,"profit":true}]

Operating Expenses	-	22.37%	(7.83%)	9.21%	(2.67%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-35.01,"profit":false},{"date":"2025-06-30","value":41.18,"profit":true},{"date":"2025-09-30","value":-11.92,"profit":false}]
Operating Income	-	(158.61%)	(570.87%)	40.32%	(0.65%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-393.36,"profit":false},{"date":"2025-03-31","value":-1415.81,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-1.62,"profit":false}]
Total Non-Operating Income/Expense	-	(0.03%)	(3.36%)	3.49%	(17.66%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-0.95,"profit":false},{"date":"2025-03-31","value":-96.37,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-506.66,"profit":false}]
Pre-Tax Income	-	93.28%	(102.92%)	755.67%	87.02%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":12.34,"profit":true},{"date":"2025-03-31","value":-13.62,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":11.52,"profit":true}]
Income Taxes	-	37.20%	(9.70%)	92.98%	(154.89%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":40.01,"profit":true},{"date":"2025-03-31","value":-10.43,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-166.59,"profit":false}]
Income After Taxes	-	90.94%	(100.12%)	15790.63%	153.67%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":0.58,"profit":true},{"date":"2025-03-31","value":-0.63,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":0.97,"profit":true}]

Income From Continuous Operations	-	90.94%	(100.12%)	15790.63%	153.67%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":0.58,"profit":true},{"date":"2025-03-31","value":-0.63,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":0.97,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	-	90.94%	(100.12%)	15790.63%	153.67%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":0.58,"profit":true},{"date":"2025-03-31","value":-0.63,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":0.97,"profit":true}]

EPS (Diluted)	-	85.71%	(100.08%)	19900.00%	700.00%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":0.43,"profit":true},{"date":"2025-03-31","value":-0.5,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":3.52,"profit":true}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Assets
Current Assets	323.80M	566.14M	516.50M	495.97M	421.97M	[{"date":"2020-12-31","value":57.19,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":91.23,"profit":true},{"date":"2023-12-31","value":87.61,"profit":true},{"date":"2024-12-31","value":74.53,"profit":true}]
Non-current Assets	10.91M	22.02M	33.50M	20.99M	68.45M	[{"date":"2020-12-31","value":15.95,"profit":true},{"date":"2021-12-31","value":32.16,"profit":true},{"date":"2022-12-31","value":48.94,"profit":true},{"date":"2023-12-31","value":30.67,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Assets	334.71M	588.15M	550.00M	516.96M	490.42M	[{"date":"2020-12-31","value":56.91,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":93.51,"profit":true},{"date":"2023-12-31","value":87.9,"profit":true},{"date":"2024-12-31","value":83.38,"profit":true}]

Total Liabilities
Current Liabilities	105.65M	103.72M	105.51M	149.99M	160.38M	[{"date":"2020-12-31","value":65.88,"profit":true},{"date":"2021-12-31","value":64.67,"profit":true},{"date":"2022-12-31","value":65.79,"profit":true},{"date":"2023-12-31","value":93.52,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Non-current Liabilities	248.32M	591.42M	739.08M	822.50M	805.97M	[{"date":"2020-12-31","value":30.19,"profit":true},{"date":"2021-12-31","value":71.91,"profit":true},{"date":"2022-12-31","value":89.86,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":97.99,"profit":true}]
Total Liabilities	353.98M	695.14M	844.60M	972.49M	966.35M	[{"date":"2020-12-31","value":36.4,"profit":true},{"date":"2021-12-31","value":71.48,"profit":true},{"date":"2022-12-31","value":86.85,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":99.37,"profit":true}]

Total Shareholders' equity
Common Stock	1.77M	1.84M	1.88M	2.06M	2.08M	[{"date":"2020-12-31","value":84.84,"profit":true},{"date":"2021-12-31","value":88.39,"profit":true},{"date":"2022-12-31","value":90.12,"profit":true},{"date":"2023-12-31","value":98.71,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Retained Earnings	(1.02B)	(1.21B)	(1.45B)	(1.68B)	(1.77B)	[{"date":"2020-12-31","value":-102344200000,"profit":false},{"date":"2021-12-31","value":-120750400000,"profit":false},{"date":"2022-12-31","value":-145462000000,"profit":false},{"date":"2023-12-31","value":-168115900000,"profit":false},{"date":"2024-12-31","value":-177004000000,"profit":false}]
Other Stockholders' Equity	(1.77M)	1.10B	1.16B	1.22B	1.29B	[{"date":"2020-12-31","value":-0.14,"profit":false},{"date":"2021-12-31","value":85.08,"profit":true},{"date":"2022-12-31","value":89.7,"profit":true},{"date":"2023-12-31","value":94.67,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Shareholders' equity	(1.02B)	(106.99M)	(294.60M)	(455.53M)	(475.93M)	[{"date":"2020-12-31","value":-102344200000,"profit":false},{"date":"2021-12-31","value":-10698600000,"profit":false},{"date":"2022-12-31","value":-29459700000,"profit":false},{"date":"2023-12-31","value":-45552800000,"profit":false},{"date":"2024-12-31","value":-47593400000,"profit":false}]

Total Liabilities & Shareholders Equity	(669.47M)	588.15M	550.00M	516.96M	490.42M	[{"date":"2020-12-31","value":-113.83,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":93.51,"profit":true},{"date":"2023-12-31","value":87.9,"profit":true},{"date":"2024-12-31","value":83.38,"profit":true}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Total Assets
Current Assets	-	74.84%	(8.77%)	(3.98%)	(14.92%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-11.71,"profit":false},{"date":"2023-12-31","value":-5.31,"profit":false},{"date":"2024-12-31","value":-19.94,"profit":false}]
Non-current Assets	-	101.69%	52.17%	(37.33%)	226.06%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":44.99,"profit":true},{"date":"2022-12-31","value":23.08,"profit":true},{"date":"2023-12-31","value":-16.51,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Total Assets	-	75.72%	(6.49%)	(6.01%)	(5.13%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-8.57,"profit":false},{"date":"2023-12-31","value":-7.93,"profit":false},{"date":"2024-12-31","value":-6.78,"profit":false}]

Total Liabilities
Current Liabilities	-	(1.83%)	1.73%	42.15%	6.93%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-4.35,"profit":false},{"date":"2022-12-31","value":4.11,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":16.44,"profit":true}]
Non-current Liabilities	-	138.17%	24.97%	11.29%	(2.01%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":18.07,"profit":true},{"date":"2023-12-31","value":8.17,"profit":true},{"date":"2024-12-31","value":-1.45,"profit":false}]
Total Liabilities	-	96.38%	21.50%	15.14%	(0.63%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":22.31,"profit":true},{"date":"2023-12-31","value":15.71,"profit":true},{"date":"2024-12-31","value":-0.65,"profit":false}]

Total Shareholders' equity
Common Stock	-	4.18%	1.95%	9.53%	1.31%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":43.91,"profit":true},{"date":"2022-12-31","value":20.5,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":13.77,"profit":true}]
Retained Earnings	-	17.98%	20.47%	15.57%	5.29%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":87.88,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":76.1,"profit":true},{"date":"2024-12-31","value":25.83,"profit":true}]
Other Stockholders' Equity	-	(62091.99%)	5.43%	5.54%	5.63%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-1102042.59,"profit":false},{"date":"2022-12-31","value":96.33,"profit":true},{"date":"2023-12-31","value":98.26,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Total Shareholders' equity	-	(89.55%)	175.36%	54.63%	4.48%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-51.06,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":31.15,"profit":true},{"date":"2024-12-31","value":2.55,"profit":true}]

Total Liabilities & Shareholders Equity	-	(187.85%)	(6.49%)	(6.01%)	(5.13%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	427.13M	421.97M	409.98M	398.46M	355.68M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":98.79,"profit":true},{"date":"2025-03-31","value":95.99,"profit":true},{"date":"2025-06-30","value":93.29,"profit":true},{"date":"2025-09-30","value":83.27,"profit":true}]
Non-current Assets	64.13M	68.45M	70.07M	58.73M	90.74M	[{"date":"2024-09-30","value":70.67,"profit":true},{"date":"2024-12-31","value":75.44,"profit":true},{"date":"2025-03-31","value":77.22,"profit":true},{"date":"2025-06-30","value":64.72,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Assets	491.25M	490.42M	480.05M	457.19M	446.42M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":99.83,"profit":true},{"date":"2025-03-31","value":97.72,"profit":true},{"date":"2025-06-30","value":93.07,"profit":true},{"date":"2025-09-30","value":90.87,"profit":true}]

Total Liabilities
Current Liabilities	153.57M	160.38M	139.85M	177.16M	190.24M	[{"date":"2024-09-30","value":80.72,"profit":true},{"date":"2024-12-31","value":84.31,"profit":true},{"date":"2025-03-31","value":73.52,"profit":true},{"date":"2025-06-30","value":93.13,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Non-current Liabilities	806.25M	805.97M	792.12M	701.62M	644.08M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":99.97,"profit":true},{"date":"2025-03-31","value":98.25,"profit":true},{"date":"2025-06-30","value":87.02,"profit":true},{"date":"2025-09-30","value":79.89,"profit":true}]
Total Liabilities	959.82M	966.35M	931.97M	878.78M	834.31M	[{"date":"2024-09-30","value":99.32,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":96.44,"profit":true},{"date":"2025-06-30","value":90.94,"profit":true},{"date":"2025-09-30","value":86.34,"profit":true}]

Total Shareholders' equity
Common Stock	2.07M	2.08M	2.09M	2.10M	2.10M	[{"date":"2024-09-30","value":98.38,"profit":true},{"date":"2024-12-31","value":99.05,"profit":true},{"date":"2025-03-31","value":99.38,"profit":true},{"date":"2025-06-30","value":99.71,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Retained Earnings	(1.74B)	(1.77B)	(1.77B)	(1.76B)	(1.75B)	[{"date":"2024-09-30","value":-174324500000,"profit":false},{"date":"2024-12-31","value":-177004000000,"profit":false},{"date":"2025-03-31","value":-177000800000,"profit":false},{"date":"2025-06-30","value":-176492300000,"profit":false},{"date":"2025-09-30","value":-175202400000,"profit":false}]
Other Stockholders' Equity	1.27B	1.29B	1.31B	1.34B	1.36B	[{"date":"2024-09-30","value":93.34,"profit":true},{"date":"2024-12-31","value":94.87,"profit":true},{"date":"2025-03-31","value":96.62,"profit":true},{"date":"2025-06-30","value":98.43,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Shareholders' equity	(468.56M)	(475.93M)	(451.93M)	(421.59M)	(387.89M)	[{"date":"2024-09-30","value":-46856300000,"profit":false},{"date":"2024-12-31","value":-47593400000,"profit":false},{"date":"2025-03-31","value":-45192700000,"profit":false},{"date":"2025-06-30","value":-42159400000,"profit":false},{"date":"2025-09-30","value":-38788900000,"profit":false}]

Total Liabilities & Shareholders Equity	491.25M	490.42M	480.05M	457.19M	446.42M	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":99.83,"profit":true},{"date":"2025-03-31","value":97.72,"profit":true},{"date":"2025-06-30","value":93.07,"profit":true},{"date":"2025-09-30","value":90.87,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	-	(1.21%)	(2.84%)	(2.81%)	(10.74%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]
Non-current Assets	-	6.74%	2.36%	(16.19%)	54.51%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":12.37,"profit":true},{"date":"2025-03-31","value":4.34,"profit":true},{"date":"2025-06-30","value":-29.7,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]
Total Assets	-	(0.17%)	(2.12%)	(4.76%)	(2.35%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]

Total Liabilities
Current Liabilities	-	4.44%	(12.80%)	26.67%	7.38%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":16.64,"profit":true},{"date":"2025-03-31","value":-47.99,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":27.67,"profit":true}]
Non-current Liabilities	-	(0.03%)	(1.72%)	(11.42%)	(8.20%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]
Total Liabilities	-	0.68%	(3.56%)	(5.71%)	(5.06%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-522.37,"profit":false},{"date":"2025-06-30","value":-838.02,"profit":false},{"date":"2025-09-30","value":-743,"profit":false}]

Total Shareholders' equity
Common Stock	-	0.68%	0.34%	0.33%	0.29%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":49.66,"profit":true},{"date":"2025-06-30","value":49.5,"profit":true},{"date":"2025-09-30","value":42.29,"profit":true}]
Retained Earnings	-	1.54%	(0.00%)	(0.29%)	(0.73%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-0.12,"profit":false},{"date":"2025-06-30","value":-18.69,"profit":false},{"date":"2025-09-30","value":-47.55,"profit":false}]
Other Stockholders' Equity	-	1.64%	1.84%	1.88%	1.59%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":86.99,"profit":true},{"date":"2025-03-31","value":97.85,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":84.57,"profit":true}]
Total Shareholders' equity	-	1.57%	(5.04%)	(6.71%)	(7.99%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-320.65,"profit":false},{"date":"2025-06-30","value":-426.67,"profit":false},{"date":"2025-09-30","value":-508.21,"profit":false}]

Total Liabilities & Shareholders Equity	-	(0.17%)	(2.12%)	(4.76%)	(2.35%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Operating Activities
Net Operating Cash Flow	(137.22M)	(142.16M)	(161.85M)	(95.14M)	(52.02M)	[{"date":"2020-12-31","value":-13721600000,"profit":false},{"date":"2021-12-31","value":-14215700000,"profit":false},{"date":"2022-12-31","value":-16185000000,"profit":false},{"date":"2023-12-31","value":-9514100000,"profit":false},{"date":"2024-12-31","value":-5202000000,"profit":false}]

Investing Activities
Net Investing Cash Flow	(6.86M)	15.80M	(128.24M)	(131.50M)	52.59M	[{"date":"2020-12-31","value":-13.04,"profit":false},{"date":"2021-12-31","value":30.05,"profit":true},{"date":"2022-12-31","value":-243.83,"profit":false},{"date":"2023-12-31","value":-250.03,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Financing Activities
Net Financing Cash Flow	302.70M	359.67M	88.03M	32.48M	(5.76M)	[{"date":"2020-12-31","value":84.16,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":24.47,"profit":true},{"date":"2023-12-31","value":9.03,"profit":true},{"date":"2024-12-31","value":-1.6,"profit":false}]

Net Change in Cash	158.63M	233.39M	(201.50M)	(193.79M)	(6.12M)	[{"date":"2020-12-31","value":67.97,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-86.34,"profit":false},{"date":"2023-12-31","value":-83.03,"profit":false},{"date":"2024-12-31","value":-2.62,"profit":false}]

Free Cash Flow
Free Cash Flow	(137.73M)	(144.54M)	(163.20M)	(97.31M)	(53.14M)	[{"date":"2020-12-31","value":-13773000000,"profit":false},{"date":"2021-12-31","value":-14454200000,"profit":false},{"date":"2022-12-31","value":-16320100000,"profit":false},{"date":"2023-12-31","value":-9730900000,"profit":false},{"date":"2024-12-31","value":-5314400000,"profit":false}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Operating Activities
Net Operating Cash Flow	-	3.60%	13.85%	(41.22%)	(45.32%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":25.99,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-297.53,"profit":false},{"date":"2024-12-31","value":-327.17,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	(330.51%)	(911.43%)	2.54%	(140.00%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-13001.34,"profit":false},{"date":"2022-12-31","value":-35852.65,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-5506.97,"profit":false}]

Financing Activities
Net Financing Cash Flow	-	18.82%	(75.53%)	(63.10%)	(117.73%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-401.28,"profit":false},{"date":"2023-12-31","value":-335.24,"profit":false},{"date":"2024-12-31","value":-625.54,"profit":false}]

Net Change in Cash	-	47.13%	(186.34%)	(3.82%)	(96.84%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-395.36,"profit":false},{"date":"2023-12-31","value":-8.11,"profit":false},{"date":"2024-12-31","value":-205.47,"profit":false}]

Free Cash Flow
Free Cash Flow	-	4.95%	12.91%	(40.37%)	(45.39%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":38.31,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-312.76,"profit":false},{"date":"2024-12-31","value":-351.59,"profit":false}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	8.24M	(5.21M)	(27.52M)	41.30M	41.11M	[{"date":"2024-09-30","value":19.96,"profit":true},{"date":"2024-12-31","value":-12.62,"profit":false},{"date":"2025-03-31","value":-66.62,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":99.54,"profit":true}]

Investing Activities
Net Investing Cash Flow	8.49M	17.80M	27.09M	29.13M	13.57M	[{"date":"2024-09-30","value":29.14,"profit":true},{"date":"2024-12-31","value":61.1,"profit":true},{"date":"2025-03-31","value":93.02,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":46.6,"profit":true}]

Financing Activities
Net Financing Cash Flow	1.27M	(4.02M)	529.00K	(73.69M)	(58.30M)	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":-315.62,"profit":false},{"date":"2025-03-31","value":41.52,"profit":true},{"date":"2025-06-30","value":-5783.83,"profit":false},{"date":"2025-09-30","value":-4576.22,"profit":false}]

Net Change in Cash	18.86M	7.26M	558.00K	(16.96M)	(3.87M)	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":38.49,"profit":true},{"date":"2025-03-31","value":2.96,"profit":true},{"date":"2025-06-30","value":-89.91,"profit":false},{"date":"2025-09-30","value":-20.51,"profit":false}]

Free Cash Flow
Free Cash Flow	8.19M	(5.89M)	(27.66M)	41.12M	39.77M	[{"date":"2024-09-30","value":19.91,"profit":true},{"date":"2024-12-31","value":-14.32,"profit":false},{"date":"2025-03-31","value":-67.26,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":96.7,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	-	(163.23%)	427.85%	(250.10%)	(0.46%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-38.15,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-58.45,"profit":false},{"date":"2025-09-30","value":-0.11,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	109.65%	52.24%	7.50%	(53.40%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":47.65,"profit":true},{"date":"2025-06-30","value":6.84,"profit":true},{"date":"2025-09-30","value":-48.71,"profit":false}]

Financing Activities
Net Financing Cash Flow	-	(415.62%)	(113.16%)	(14029.30%)	(20.88%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]

Net Change in Cash	-	(61.51%)	(92.31%)	(3138.71%)	(77.19%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]

Free Cash Flow
Free Cash Flow	-	(171.93%)	369.77%	(248.67%)	(3.30%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-46.5,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-67.25,"profit":false},{"date":"2025-09-30","value":-0.89,"profit":false}]

BioCryst Pharmaceuticals Inc Ratios

BioCryst Pharmaceuticals Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

	BCRX
Cash Ratio	1.12
Current Ratio	1.87
Quick Ratio	1.84

BioCryst Pharmaceuticals Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	BCRX
ROA (LTM)	10.31%
ROE (LTM)	-1925.37%

BioCryst Pharmaceuticals Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	BCRX
Debt Ratio Lower is generally better. Negative is bad.	1.87
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	-0.87

BioCryst Pharmaceuticals Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	BCRX
Trailing PE	NM
Forward PE	454.55
P/S (TTM)	2.87
P/B	56.59
Price/FCF	43
EV/R	3.52
EV/Ebitda	25.15
PEG	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is BioCryst Pharmaceuticals Inc share price today?

BioCryst Pharmaceuticals Inc (BCRX) share price today is $7.26

Can Indians buy BioCryst Pharmaceuticals Inc shares?

Yes, Indians can buy shares of BioCryst Pharmaceuticals Inc (BCRX) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BCRX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of BioCryst Pharmaceuticals Inc be purchased?

Yes, you can purchase fractional shares of BioCryst Pharmaceuticals Inc (BCRX) via the Vested app. You can start investing in BioCryst Pharmaceuticals Inc (BCRX) with a minimum investment of $1.

How to invest in BioCryst Pharmaceuticals Inc shares from India?

You can invest in shares of BioCryst Pharmaceuticals Inc (BCRX) via Vested in three simple steps:

Click on Sign Up or Invest in BCRX stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in BioCryst Pharmaceuticals Inc shares

What is BioCryst Pharmaceuticals Inc 52-week high and low stock price?

The 52-week high price of BioCryst Pharmaceuticals Inc (BCRX) is $11.31. The 52-week low price of BioCryst Pharmaceuticals Inc (BCRX) is $6.

What is BioCryst Pharmaceuticals Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of BioCryst Pharmaceuticals Inc (BCRX) is

What is BioCryst Pharmaceuticals Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of BioCryst Pharmaceuticals Inc (BCRX) is 56.59

What is BioCryst Pharmaceuticals Inc dividend yield?

The dividend yield of BioCryst Pharmaceuticals Inc (BCRX) is 0.00%

What is the Market Cap of BioCryst Pharmaceuticals Inc?

The market capitalization of BioCryst Pharmaceuticals Inc (BCRX) is $1.72B

What is BioCryst Pharmaceuticals Inc's stock symbol?

The stock symbol (or ticker) of BioCryst Pharmaceuticals Inc is BCRX

How Can Investors Use BioCryst Pharmaceuticals Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of BioCryst Pharmaceuticals Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether BioCryst Pharmaceuticals Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from BioCryst Pharmaceuticals Inc shares for Indian investors?

When investing in BioCryst Pharmaceuticals Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the BioCryst Pharmaceuticals Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare BioCryst Pharmaceuticals Inc share price with other stocks in the same sector?

Rather than merely checking the share price of BioCryst Pharmaceuticals Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that BioCryst Pharmaceuticals Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

BioCryst Pharmaceuticals Inc Share Price

BioCryst Pharmaceuticals Inc Analyst Forecast

BioCryst Pharmaceuticals Inc Share Price Chart

BioCryst Pharmaceuticals Inc Key Stock Metrics

About BioCryst Pharmaceuticals Inc, Common Stock

BioCryst Pharmaceuticals Inc Stock Returns

BioCryst Pharmaceuticals Inc Financials

BioCryst Pharmaceuticals Inc Ratios

BioCryst Pharmaceuticals Inc Liquidity Ratios

BioCryst Pharmaceuticals Inc Asset Efficiency Ratios

BioCryst Pharmaceuticals Inc Liability Ratios

BioCryst Pharmaceuticals Inc Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Company

Explore Products

Popular US Stocks ¹

Popular US ETFs ²

Curated Portfolios (Vests)

Risk Disclosure - US Markets

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

BioCryst Pharmaceuticals Inc Share Price

BioCryst Pharmaceuticals Inc Analyst Forecast

BioCryst Pharmaceuticals Inc Share Price Chart

BioCryst Pharmaceuticals Inc Key Stock Metrics

About BioCryst Pharmaceuticals Inc, Common Stock

BioCryst Pharmaceuticals Inc Stock Returns

BioCryst Pharmaceuticals Inc Financials

BioCryst Pharmaceuticals Inc Ratios

BioCryst Pharmaceuticals Inc Liquidity Ratios

BioCryst Pharmaceuticals Inc Asset Efficiency Ratios

BioCryst Pharmaceuticals Inc Liability Ratios

BioCryst Pharmaceuticals Inc Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

Popular US Stocks ¹

Popular US ETFs ²